Oklahoma Supreme Court throws out $465 million opioid verdict against Johnson & Johnson
The Oklahoma Supreme Court on Tuesday overturned a $465 million judgement against Johnson & Johnson for its role in marketing, selling, and distributing opioids in the state. The 5-1 ruling found that Cleveland County District Judge Thad Balkman and state prosecutors had incorrectly used public nuisance laws to find Johnson & Johnson culpable in 2019.
"In reaching this decision, we do not minimize the severity of the harm that thousands of Oklahoma citizens have suffered because of opioids," the Oklahoma Supreme Court majority wrote in its ruling. "However grave the problem of opioid addiction is in Oklahoma, public nuisance law does not provide a remedy for this harm." The lone dissenter said the ruling should have been sent back to the lower court.
This is the second blow against the use of public nuisance laws against companies involved in the sale and distribution of opioids; a California judge tentatively ruled last week that several large counties had not proved opioid companies had violated public nuisance laws because they had failed to show that deceptive marketing had increased prescription abuse. Public nuisance laws are being used against opioid companies across the U.S. as states and local governments try to get restitution for an opioid crisis blamed for more than 500,000 deaths in 20 years.
The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
Johnson & Johnson praised the Oklahoma ruling while state Attorney General John O'Connor said he was "disappointed" the Supreme Court had voided "a huge victory for Oklahoma citizens and their families who have been ravaged by opioids." He said his office will explore its options.
Are these two rulings against opioid flooding as a public nuisance "outlier opinions or are they trendsetters?" Elizabeth Burch, a University of Georgia law professor, told The Washington Post. "I think it's too early to be able to tell right now." There's a lot more opioid litigation on the horizon, she added, so "there's a lot that remains to be seen.
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Peter has worked as a news and culture writer and editor at The Week since the site's launch in 2008. He covers politics, world affairs, religion and cultural currents. His journalism career began as a copy editor at a financial newswire and has included editorial positions at The New York Times Magazine, Facts on File, and Oregon State University.
-
Political cartoons for October 25Cartoons Saturday’s political cartoons include hospital bill trauma, Independence Day, and more
-
Roasted squash and apple soup recipeThe Week Recommends Autumnal soup is full of warming and hearty flavours
-
Ukraine: Donald Trump pivots againIn the Spotlight US president apparently warned Volodymyr Zelenskyy to accept Vladimir Putin’s terms or face destruction during fractious face-to-face
-
Can TrumpRx really lower drug prices?Today’s Big Question Pfizer’s deal with Trump sent drugmaker stocks higher
-
FDA OKs generic abortion pill, riling the rightSpeed Read The drug in question is a generic version of mifepristone, used to carry out two-thirds of US abortions
-
RFK Jr. vaccine panel advises restricting MMRV shotSpeed Read The committee voted to restrict access to a childhood vaccine against chickenpox
-
The UK’s opioid crisis: why the stats don’t add upThe Explainer A new report has revealed that the UK’s total of opioid-related deaths could be much greater than official figures show
-
Texas declares end to measles outbreakSpeed Read The vaccine-preventable disease is still spreading in neighboring states, Mexico and Canada
-
RFK Jr. shuts down mRNA vaccine funding at agencySpeed Read The decision canceled or modified 22 projects, primarily for work on vaccines and therapeutics for respiratory viruses
-
Why the FDA wants to restrict kratom-related productsIn the Spotlight The compound is currently sold across the United States
-
Measles cases surge to 33-year highSpeed Read The infection was declared eliminated from the US in 2000 but has seen a resurgence amid vaccine hesitancy
